Skip to main navigation
TCR2 Staging

Corporate Menu & Investor Relations

Pipeline Contact
About TCR² Leadership Partners Community
Our Approach The Truc Platform Publications
Press Releases In the News Awards
Overview Events Presentations Corporate Governance SEC Filings Stock Information Analyst Coverage FAQs
Careers Community
investors.jpg
TCR2 Investors

Corporate Menu & Investor Relations

About Us About TCR² Leadership Partners Community Technology Our Approach The Truc Platform Publications Pipeline News Press Releases In the News Awards Investors Overview Events Presentations Corporate Governance SEC Filings Stock Information Analyst Coverage FAQs Careers Careers Community Contact

Press Releases

Latest Press Releases | In The News

Press Releases

All News | 2020 | 2019 | 2018 | 2017 | 2016 |

Dec 07, 2016

TCR² Therapeutics Launches from Stealth Mode to Accelerate Development of Novel Cancer Immunotherapies 315 KB

Tools

  • Print Page
  • RSS Feeds
  • Email Alerts
  • Contact IR
TCR2
 

100 Binney Street, Suite 710
Cambridge, MA 02142
617.949.5200

TERMS OF USE

Corporate Menu & Investor Relations

About Us
Technology
Pipeline
News
Investors
Careers
Contact